Report

Acquisition intéressante, mais flottant en extinction - APPORTER vs ACHAT - OC 27€ (vs 25,5€)

L’acquisition récente de deux portefeuilles hôteliers majeurs nous incite à relever nos perspectives de croissance des résultats. Toutefois, la très forte surperformance en 2015 a rendu la valorisation moins attractive, pour un titre aux perspectives à moyen terme et au rendement certes très solides, mais dont (i) le court terme reste impacté par la baisse de fréquentation en Ile-de-France, et (ii) le flottant devient de plus en plus limité suite au renforcement progressif de FDR. Nous relevons notre objectif à 27€ fin 2016 vs 25,5€, qui traduit un P/CF 2016e de 14,8x, un rendement du dividende de 5,7%, et une prime sur le dernier ANR publié de +13,4%. Notre objectif sur FDR étant ajusté ce jour à 85€, nous recommandons aux actionnaires de FDM d’APPORTER à l’offre d’échange de FDR, qui valorise actuellement FDM 26,8€/action, et la valoriserait 28,3€ si notre objectif de cours sur FDR était atteint, sans compter une liquidité sans commune mesure.
Underlying
Covivio Hotels SCA

Fonciere Des Murs is a real estate company. Co. specializes in the long-term holding of operating facilities in the hotel, health-care, leisure and restaurant sectors. Co. is also engaged in the development of business premises. Co. is a partner with groups seeking to outsource their property assets and those seeking to have their operating facilities managed by professionals. As of Dec 31 2010, Co.'s portfolio comprised 187 hotels, 3 seawater-therapy institutes, 47 nursing homes, 3 follow-up care and rehabilitation clinics, 2 psychiatric clinics, 4 surgery clinics, 177 restaurants, 58 garden centres and 5 holiday villages.

Provider
Invest Securities
Invest Securities

Since 2006, Invest Securities has become one of the leading players in investment services for funds and managers, to whom we offer a global and personalised service. Our track record differentiates us and proves our leadership in numerous promising sectors like property and growth companies.

Consisting of 13 different profiles (pharmacist, engineer, financier, etc), the DNA of our financial analysis office is value added and sector expertise. Through daily monitoring and detailed analyses of companies and sectors, we seek to provide a differentiating vision of our 120 stocks followed. Our ideas are circulated every day to nearly 1,000 professionals.

ResearchPool Subscriptions

Get the most out of your insights

Get in touch